Thursday, June 19th, 2025
Stock Profile: PHAT

Phathom Pharmaceuticals, Inc. (PHAT)

Market: NASD | Currency: USD

Address: 100 Campus Drive

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.




📈 Phathom Pharmaceuticals, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for Phathom Pharmaceuticals, Inc.


DateReported EPS
2026-04-29 (estimated upcoming)-
2026-03-04 (estimated upcoming)-
2025-11-05 (estimated upcoming)-
2025-11-04 (estimated upcoming)-
2025-08-06 (estimated upcoming)-
2025-08-05 (estimated upcoming)-
2025-05-07-
2025-05-06-
2025-05-01-1.31
2025-03-06-1.05
2025-03-04-
2024-11-07-1.32
2024-08-08-1.56
2024-08-07-1.56
2024-05-09-1.42
2024-05-08-1.42
2024-03-07-1.39
2024-03-06-1.39
2023-11-09-0.76
2023-11-08-0.76
2023-08-10-0.84
2023-08-09-0.84
2023-05-10-0.89
2023-05-09-0.89
2023-02-28-1.33
2023-02-27-1.33
2022-11-08-1.32
2022-11-07-1.32
2022-08-02-1.33
2022-08-01-1.33
2022-05-10-1.07
2022-05-09-1.07
2022-03-01-0.95
2022-02-28-0.95
2021-11-08-0.98
2021-11-07-0.98
2021-08-10-1
2021-08-09-1
2021-05-11-0.96
2021-05-10-0.96
2021-03-30-1.58
2021-03-29-1.58
2020-11-10-1.02
2020-11-09-1.02
2020-08-06-0.64
2020-08-05-0.64
2020-05-12-0.62
2020-05-11-0.62
2020-03-19-3.97
2020-03-18-3.97
2019-11-24-9.3
2019-10-27-




📰 Related News & Research


No related articles found for "phathom pharmaceuticals".